Obioha scores 20, Niagara defeats NJIT 89-81
Published Dec. 16, 2023 3:28 p.m. ET
Associated Press
LEWISTON, N.Y. (AP) — Harlan Obioha had 20 points and grabbed 15 rebounds in Niagara's 89-81 win against NJIT on Saturday.
Luke Bumbalough scored 14 points and added five rebounds for the Purple Eagles (3-6). Yaw Obeng-Mensah finished with 14 points.
Tariq Francis led the Highlanders (2-8) in scoring, finishing with 20 points. Kjell de Graaf added 17 points for NJIT. Mekhi Gray had 13 points.
___
The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.
share
recommended
Last Night in College Basketball: Iowa State, Iowa Played a Wild Back-And-Forth
Top 25 college athletes with highest NIL valuations
4 Takeaways From No. 5 UConn's 71-63 Win Over Texas
2025-26 Men's March Madness Odds: Michigan Becomes New Favorite
Purdue HC Matt Painter on Losing No. 1 Ranking: 'It Really Isn't That Important'
115-Year-Old Boston Arena Where Babe Ruth Played Hockey — Yes, Hockey — Closing
Last Night in College Basketball: No. 10 Iowa State Passes Test vs. No. 11 Iowa
College Basketball Top 10, Bubble Team NET Rankings: Michigan, UConn are No. 1
Top 10 men's college basketball players with highest NIL valuations
Item 1 of 3
recommended
Last Night in College Basketball: Iowa State, Iowa Played a Wild Back-And-Forth
Top 25 college athletes with highest NIL valuations
4 Takeaways From No. 5 UConn's 71-63 Win Over Texas
2025-26 Men's March Madness Odds: Michigan Becomes New Favorite
Purdue HC Matt Painter on Losing No. 1 Ranking: 'It Really Isn't That Important'
115-Year-Old Boston Arena Where Babe Ruth Played Hockey — Yes, Hockey — Closing
Last Night in College Basketball: No. 10 Iowa State Passes Test vs. No. 11 Iowa
College Basketball Top 10, Bubble Team NET Rankings: Michigan, UConn are No. 1
Top 10 men's college basketball players with highest NIL valuations
Item 1 of 3
FOX SPORTS™, SPEED™, SPEED.COM™ & © 2025 Fox Media LLC
and Fox Sports Interactive Media, LLC. All rights reserved. Use of this
website (including any and all parts and components) constitutes your
acceptance of these
Terms of Use and Privacy Policy | Advertising Choices | Your Privacy Choices | Closed Captioning
